Form 4: Edwards Lifesciences Executive Daveen Chopra Reports Stock Sale
SEC Filing
Daveen Chopra, CVP at Edwards Lifesciences, reported the sale of 1,500 shares of common stock at a price of $75.075 on May 22, 2025.
Summary
- On May 22, 2025, Daveen Chopra, CVP of TMTT at Edwards Lifesciences Corp, sold 1,500 shares of common stock.
- The sale price was $75.075 per share.
- Following the transaction, Chopra directly owns 33,496 shares of Edwards Lifesciences common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of a stock sale by an executive, with no inherent positive or negative implications for the company's overall outlook.
Industry Context
Executive stock sales are a common occurrence and are often related to personal financial planning rather than a reflection of the company's performance.
Stakeholder Impact
- The sale of shares by an executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction.
Key Dates
| Date | Description |
|---|---|
| 05/22/2025 | Date of stock sale transaction |
Keywords
Form 4, Executive Stock Sale, Daveen Chopra, Edwards Lifesciences, EW, Stock Sale, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.